Developer docs
API playgroundTry for free, no card

Search company profiles

shiftzero k k

Full company profile

uuid02m8jva

Namestring
shiftzero k k
Legal namestring
株式会社シフトゼロ
Websiteurl
shiftzerokk.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

ShiftZero K.K. is a privately held Tokyo-based B2B professional-services company founded on November 19, 2014, that supports pharmaceutical companies across the drug lifecycle. Its Consulting Division provides market research and analysis, development plans, trial design, clinical-trial consultation, promotion strategy, and post-marketing clinical study planning. Its Marketing Division creates medical and promotional materials, supports publications, plans advisory boards, lectures, and congress exhibitions, and conducts physician qualitative research and patient journey mapping.

The operating model coordinates development-stage work with post-marketing activities and feeds real-world clinical-practice insights back into development planning, with the stated aim of supporting product introduction and branding across phases. Clients engage the firm through direct, personalized B2B contact initiated through its website or email inquiries. Pricing, headcount, revenue, customer counts, proprietary technology, and measurable outcomes are not disclosed; its disclosed distribution footprint is domestic Japan, and the operating model is professional services rather than product or subscription revenue.

Short descriptiontext

ShiftZero K.K. is a Tokyo-based B2B pharmaceutical services firm supporting drug development and commercialization through consulting, clinical planning, trial-design consultation, promotional materials, events, and market research for pharmaceutical companies throughout the product lifecycle.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting, drug lifecycle management, clinical development planning, medical marketing services, post-marketing support
Industry2 codes
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Consulting Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

ShiftZero K.K. generates revenue through consulting and professional services for pharmaceutical companies, including market research, strategic development planning, clinical trial design, regulatory consultation, and post-marketing promotional activities. Services are provided throughout the entire drug lifecycle.

shiftzerokk.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ShiftZero K.K. is a pharmaceutical consulting firm that supports pharmaceutical companies across the entire drug lifecycle. Through its Consulting Division, the company delivers market research, strategic development planning, trial design, clinical trial consultation, and promotion strategy development. Through its Marketing Division, it produces medical and promotional materials, manages publication support, plans advisory boards and medical congresses, and runs physician qualitative surveys and patient journey mapping for pharmaceutical clients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ShiftZero K.K. is a pharmaceutical consulting company that provides integrated services throughout the entire drug lifecycle. The company operates through two main divisions: the Consulting Division handles market research, strategic development planning, trial design, and clinical consultation, while the Marketing Division manages creation of promotional and educational materials, publication support, meeting and event planning, and market research services. Together, these divisions coordinate to support drug development from planning through post-marketing promotional activities.

Product and service2 records
1Consulting Division Services (コンサルティング部門)
CategoryPharmaceutical consulting
2Marketing Division Services (マーケティング本部)
CategoryPharmaceutical marketing and communications
Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Artemida Pharma is listed as a business partner on ShiftZero K.K.'s website. The partnership appears to be a strategic alliance within the pharmaceutical services ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

CMIC Holdings, a major Japanese pharmaceutical services company (CRO), is listed as a business partner. CMIC provides contract research organization services, potentially complementing ShiftZero's lifecycle management offerings.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prescient Healthcare Group, a healthcare intelligence company, is listed as a business partner. The partnership may provide strategic intelligence capabilities to support ShiftZero's consulting and marketing services.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Japan's largest CRO and listed pharma-services platform offering clinical development, post-marketing services, and consulting. Listed as a ShiftZero business partner, CMIC operates one rung up the value chain with the same pharma sponsor base but at markedly greater scale and breadth.

TypeDirect peer
Description

Healthcare intelligence and strategic advisory firm that supports pharma clients with competitive intelligence, market research, and pipeline strategy — overlapping squarely with ShiftZero's Consulting Division services and also a ShiftZero partner.

TypeBroad incumbent
Description

Global leader in clinical research, real-world evidence, and pharma consulting with a substantial Japan presence. Competes for the same strategic-development and post-marketing advisory mandates that ShiftZero targets among Japanese pharma sponsors.

TypeDirect peer
Description

Japan-based CRO/clinical services firm spun off from a major Japanese pharma, providing clinical development and post-marketing support to pharma companies — directly comparable in service mix and target buyer to ShiftZero.

5EPS Holdings
TypeBroad incumbent
Description

Japanese CRO and healthcare services group offering clinical research, post-marketing, and CRO-related consulting. Significantly larger than ShiftZero with an overlapping pharma-sponsor client base in Japan.

6INTAGE Healthcare
TypeDirect peer
Description

Japanese market-research and consulting firm focused on healthcare/pharma, providing physician surveys, patient journey analysis, and market insight — directly overlapping with ShiftZero's market-research and physician qualitative survey offerings.

7ZS Associates
TypeBroad incumbent
Description

Global management consulting firm with a large pharma and life sciences practice covering strategy, launch planning, and commercial operations — addressing the same client problem space as ShiftZero but at much greater scale and geographic reach.

TypeBroad incumbent
Description

Global top-tier management consulting firm with a deep pharma and medical-products practice advising on strategy, R&D, and commercial excellence — competes for the same high-stakes lifecycle and launch mandates as ShiftZero.

TypeEmerging player
Description

Pharma-focused strategic partner listed on ShiftZero's partner page, operating in the Japanese pharma services ecosystem with overlapping capabilities around development strategy and commercialization support for emerging/specialty pharma.

10Medipal Holdings (Pharma Services)
TypeRegional player
Description

Major Japanese pharma distribution and services group whose services arm supports pharma manufacturers with post-marketing and commercial support functions. Comparable buyer type (Japan pharma manufacturers) and adjacent capability footprint to ShiftZero.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

shiftzero k k

Pharmaceutical Consulting Servicesshiftzerokk.com

ShiftZero K.K. is a Tokyo-based B2B pharmaceutical services firm supporting drug development and commercialization through consulting, clinical planning, trial-design consultation, promotional materials, events, and market research for pharmaceutical companies throughout the product lifecycle.

What shiftzero k k does

ShiftZero K.K. is a privately held Tokyo-based B2B professional-services company founded on November 19, 2014, that supports pharmaceutical companies across the drug lifecycle. Its Consulting Division provides market research and analysis, development plans, trial design, clinical-trial consultation, promotion strategy, and post-marketing clinical study planning. Its Marketing Division creates medical and promotional materials, supports publications, plans advisory boards, lectures, and congress exhibitions, and conducts physician qualitative research and patient journey mapping.

The operating model coordinates development-stage work with post-marketing activities and feeds real-world clinical-practice insights back into development planning, with the stated aim of supporting product introduction and branding across phases. Clients engage the firm through direct, personalized B2B contact initiated through its website or email inquiries. Pricing, headcount, revenue, customer counts, proprietary technology, and measurable outcomes are not disclosed; its disclosed distribution footprint is domestic Japan, and the operating model is professional services rather than product or subscription revenue.

shiftzero k k firmographics

Firmographics
Name
shiftzero k k
Legal name
株式会社シフトゼロ
Website
https://shiftzerokk.com
Company type
Private
Founded year
2014
Operating status
Operating
Short description
ShiftZero K.K. is a Tokyo-based B2B pharmaceutical services firm supporting drug development and commercialization through consulting, clinical planning, trial-design consultation, promotional materials, events, and market research for pharmaceutical companies throughout the product lifecycle.
Ownership category
akta.pro rank

shiftzero k k industry classification

Industry
Product category
Pharmaceutical Consulting Services
NAICS
Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pharmaceutical consulting
  • Drug lifecycle management
  • Clinical development planning
  • Medical marketing services
  • Post-marketing support

Where shiftzero k k is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

shiftzero k k business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Consulting Services: ShiftZero K.K. generates revenue through consulting and professional services for pharmaceutical companies, including market research, strategic development planning, clinical trial design, regulatory consultation, and post-marketing promotional activities. Services are provided throughout the entire drug lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

shiftzero k k product offering

Product offering

Core offering

ShiftZero K.K. is a pharmaceutical consulting firm that supports pharmaceutical companies across the entire drug lifecycle. Through its Consulting Division, the company delivers market research, strategic development planning, trial design, clinical trial consultation, and promotion strategy development. Through its Marketing Division, it produces medical and promotional materials, manages publication support, plans advisory boards and medical congresses, and runs physician qualitative surveys and patient journey mapping for pharmaceutical clients.

Product overview

ShiftZero K.K. is a pharmaceutical consulting company that provides integrated services throughout the entire drug lifecycle. The company operates through two main divisions: the Consulting Division handles market research, strategic development planning, trial design, and clinical consultation, while the Marketing Division manages creation of promotional and educational materials, publication support, meeting and event planning, and market research services. Together, these divisions coordinate to support drug development from planning through post-marketing promotional activities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Consulting Division Services (コンサルティング部門)
  • Marketing Division Services (マーケティング本部)

Companies that use shiftzero k k

Customer profile

Segments1 record

Ideal customer profiles1 record

shiftzero k k technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

shiftzero k k partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • Artemida PharmaminorStrategic or Co-development PartnerArtemida Pharma is listed as a business partner on ShiftZero K.K.'s website. The partnership appears to be a strategic alliance within the pharmaceutical services ecosystem.
  • CMIC Holdings Co., Ltd. (シミックホールディングス株式会社)minorStrategic or Co-development PartnerCMIC Holdings, a major Japanese pharmaceutical services company (CRO), is listed as a business partner. CMIC provides contract research organization services, potentially complementing ShiftZero's lifecycle management offerings.
  • Prescient Healthcare GroupminorStrategic or Co-development PartnerPrescient Healthcare Group, a healthcare intelligence company, is listed as a business partner. The partnership may provide strategic intelligence capabilities to support ShiftZero's consulting and marketing services.

Recent moves3 records

Expansion highlights3 records

shiftzero k k competitors and assessment

Company assessment

Broad incumbents

  • CMIC Holdings: Japan's largest CRO and listed pharma-services platform offering clinical development, post-marketing services, and consulting. Listed as a ShiftZero business partner, CMIC operates one rung up the value chain with the same pharma sponsor base but at markedly greater scale and breadth.
  • IQVIA Japan: Global leader in clinical research, real-world evidence, and pharma consulting with a substantial Japan presence. Competes for the same strategic-development and post-marketing advisory mandates that ShiftZero targets among Japanese pharma sponsors.
  • EPS Holdings: Japanese CRO and healthcare services group offering clinical research, post-marketing, and CRO-related consulting. Significantly larger than ShiftZero with an overlapping pharma-sponsor client base in Japan.
  • ZS Associates: Global management consulting firm with a large pharma and life sciences practice covering strategy, launch planning, and commercial operations — addressing the same client problem space as ShiftZero but at much greater scale and geographic reach.
  • McKinsey & Company (Pharma Practice): Global top-tier management consulting firm with a deep pharma and medical-products practice advising on strategy, R&D, and commercial excellence — competes for the same high-stakes lifecycle and launch mandates as ShiftZero.

Direct peers

  • Prescient Healthcare Group: Healthcare intelligence and strategic advisory firm that supports pharma clients with competitive intelligence, market research, and pipeline strategy — overlapping squarely with ShiftZero's Consulting Division services and also a ShiftZero partner.
  • A2 Healthcare Corporation: Japan-based CRO/clinical services firm spun off from a major Japanese pharma, providing clinical development and post-marketing support to pharma companies — directly comparable in service mix and target buyer to ShiftZero.
  • INTAGE Healthcare: Japanese market-research and consulting firm focused on healthcare/pharma, providing physician surveys, patient journey analysis, and market insight — directly overlapping with ShiftZero's market-research and physician qualitative survey offerings.

Emerging players

  • Artemida Pharma: Pharma-focused strategic partner listed on ShiftZero's partner page, operating in the Japanese pharma services ecosystem with overlapping capabilities around development strategy and commercialization support for emerging/specialty pharma.

Regional players

  • Medipal Holdings (Pharma Services): Major Japanese pharma distribution and services group whose services arm supports pharma manufacturers with post-marketing and commercial support functions. Comparable buyer type (Japan pharma manufacturers) and adjacent capability footprint to ShiftZero.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat1 record

Key risks5 records

Key highlights5 records

Customer concentration

shiftzero k k social profiles

Digital presence

shiftzero k k financial estimates

Financial estimate

Revenue estimate

Valuation estimate

shiftzero k k leadership team

Management profile

Number of profiles

Profiles1 record

shiftzero k k funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

shiftzero k k M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about shiftzero k k

What does shiftzero k k do?

ShiftZero K.K. is a pharmaceutical consulting firm that supports pharmaceutical companies across the entire drug lifecycle. Through its Consulting Division, the company delivers market research, strategic development planning, trial design, clinical trial consultation, and promotion strategy development. Through its Marketing Division, it produces medical and promotional materials, manages publication support, plans advisory boards and medical congresses, and runs physician qualitative surveys and patient journey mapping for pharmaceutical clients.

Is shiftzero k k a public or private company?

shiftzero k k is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was shiftzero k k founded?

shiftzero k k was founded in 2014.

Where is shiftzero k k based?

shiftzero k k is headquartered in Tokyo, Japan, in the Asia region.

How does shiftzero k k make money?

One revenue line is on record: consulting Services.

Who are shiftzero k k's main competitors?

Broad incumbents on record are CMIC Holdings, IQVIA Japan, EPS Holdings, ZS Associates and McKinsey & Company (Pharma Practice). Direct peers are Prescient Healthcare Group, A2 Healthcare Corporation and INTAGE Healthcare. Artemida Pharma is listed as an emerging player. Medipal Holdings (Pharma Services) is listed as a regional player.

Does shiftzero k k have an API?

No public API is recorded for shiftzero k k.

What industry is shiftzero k k in?

shiftzero k k's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales